Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8DZK

Dbr1 in complex with 5-mer cleavage product

Summary for 8DZK
Entry DOI10.2210/pdb8dzk/pdb
DescriptorRNA lariat debranching enzyme, putative, RNA (5'-R(P*(G46)P*UP*GP*UP*U)-3'), FE (II) ION, ... (6 entities in total)
Functional Keywordsmetalloenzyme, complex, branched rna, hydrolase-rna complex, rna binding protein, hydrolase/rna
Biological sourceEntamoeba histolytica
More
Total number of polymer chains10
Total formula weight215245.13
Authors
Clark, N.E.,Taylor, A.B. (deposition date: 2022-08-08, release date: 2022-08-24, Last modification date: 2023-10-25)
Primary citationClark, N.E.,Katolik, A.,Welch, A.,Schorl, C.,Holloway, S.P.,Schuermann, J.P.,Hart, P.J.,Taylor, A.B.,Damha, M.J.,Fairbrother, W.G.
Crystal Structure of the RNA Lariat Debranching Enzyme Dbr1 with Hydrolyzed Phosphorothioate RNA Product.
Biochemistry, 61:2933-2939, 2022
Cited by
PubMed Abstract: The RNA lariat debranching enzyme is the sole enzyme responsible for hydrolyzing the 2'-5' phosphodiester bond in RNA lariats produced by the spliceosome. Here, we test the ability of Dbr1 to hydrolyze branched RNAs (bRNAs) that contain a 2'-5'-phosphorothioate linkage, a modification commonly used to resist degradation. We attempted to cocrystallize a phosphorothioate-branched RNA (PS-bRNA) with wild-type Dbr1 (EhDbr1) but observed in-crystal hydrolysis of the phosphorothioate bond. The crystal structure revealed EhDbr1 in a product-bound state, with the hydrolyzed 2'-5' fragment of the PS-bRNA mimicking the binding mode of the native bRNA substrate. These findings suggest that product inhibition may contribute to the kinetic mechanism of Dbr1. We show that Dbr1 enzymes cleave phosphorothioate linkages at rates ∼10,000-fold more slowly than native phosphate linkages. This new product-bound crystal structure offers atomic details, which can aid inhibitor design. Dbr1 inhibitors could be therapeutic or investigative compounds for human diseases such as human immunodeficiency virus (HIV), amyotrophic lateral sclerosis (ALS), cancer, and viral encephalitis.
PubMed: 36484984
DOI: 10.1021/acs.biochem.2c00590
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon